Clinical Trial Detail

NCT ID NCT03295396
Title ONC201 in Adults With Recurrent H3 K27M-mutant Glioma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Oncoceutics, Inc.
Indications

malignant glioma

Therapies

ONC201

Age Groups: senior adult

No variant requirements are available.